These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32732918)

  • 1. Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites.
    Makunts T; Wollmer MA; Abagyan R
    Sci Rep; 2020 Jul; 10(1):12851. PubMed ID: 32732918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety.
    Wollmer MA; Makunts T; Krüger THC; Abagyan R
    Sci Rep; 2021 Dec; 11(1):24173. PubMed ID: 34934096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aesthetic uses of the botulinum toxin.
    Dorizas A; Krueger N; Sadick NS
    Dermatol Clin; 2014 Jan; 32(1):23-36. PubMed ID: 24267419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes.
    Glogau RG
    Clin J Pain; 2002; 18(6 Suppl):S191-7. PubMed ID: 12569968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.
    Yamauchi PS; Lowe NJ
    Clin Dermatol; 2004; 22(1):34-9. PubMed ID: 15158543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shrink that frown! Botulinum toxin therapy is lifting the face of psychiatry.
    Wollmer MA; Neumann I; Magid M; Kruger TH
    G Ital Dermatol Venereol; 2018 Aug; 153(4):540-548. PubMed ID: 29667799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations.
    Alimohammadi M; Punga AR
    Toxins (Basel); 2017 Oct; 9(11):. PubMed ID: 29084148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of botulinum neurotoxin for spasticity].
    Mukai Y; Kaji R
    Brain Nerve; 2008 Dec; 60(12):1421-6. PubMed ID: 19110753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Depression with Botulinum Toxin.
    Wollmer MA; Magid M; Kruger THC; Finzi E
    Toxins (Basel); 2022 May; 14(6):. PubMed ID: 35737044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Skin, wrinkles and botulinum toxin].
    Nicolau PJ; Chaouat M; Mimoun M
    Ann Readapt Med Phys; 2003 Jul; 46(6):361-74. PubMed ID: 12928144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population.
    Kolaski K; Ajizian SJ; Passmore L; Pasutharnchat N; Koman LA; Smith BP
    Am J Phys Med Rehabil; 2008 Jul; 87(7):556-66. PubMed ID: 18574347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology of botulinum neurotoxin serotype A: a cosmetic perspective.
    Eapen BR
    J Cosmet Dermatol; 2008 Sep; 7(3):221-5. PubMed ID: 18789058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia].
    Halb L; Amann BJ; Bornemann-Cimenti H
    Nervenarzt; 2017 Apr; 88(4):408-414. PubMed ID: 27924350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type B for glabellar wrinkles: a prospective open-label response study.
    Sadick NS; Faacs
    Dermatol Surg; 2002 Sep; 28(9):817-21. PubMed ID: 12269875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of botulinum toxin in pregnancy and its impact on female reproductive health.
    Li W; Tang M
    Expert Opin Drug Saf; 2020 Jan; 19(1):83-91. PubMed ID: 31868020
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines.
    Carruthers A; Carruthers J; Flynn TC; Leong MS
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S60-8. PubMed ID: 17241416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin-B and the management of hyperhidrosis.
    Baumann LS; Halem ML
    Clin Dermatol; 2004; 22(1):60-5. PubMed ID: 15158547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controversy: botulinum toxin, does it prevent cutaneous aging?].
    Cohen-Letessier A
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S89-91. PubMed ID: 19576492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type B (Myobloc).
    Baumann L; Black L
    Dermatol Surg; 2003 May; 29(5):496-500; discussion 500. PubMed ID: 12752517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.